No Data
No Data
EUDA Health Holdings Full Year 2024 Earnings: US$0.54 Loss per Share (Vs US$0.37 Loss in FY 2023)
20-F: FY2024 Annual Report
EUDA Health Holdings Expands Healthcare Offerings With New COO and Strategic Partnership
EUDA Enters Partnership With Authorized Distributor Of Guangdong Cell Biotech To Offer Stem Cell Therapies To Customers In Singapore And Malaysia
Leadership Transition at EUDA Health Holdings: New CEO Appointed
Express News | EUDA Health Holdings Ltd: On Feb 8, Approved & Appointed Alfred Lim as Co's CEO